Soraya Olmo-Curiel

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway.

Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway.

Journal: Molecular genetics & genomic medicine
Published: February 24, 2024

Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home.

Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home.

Journal: Scientific reports
Published: January 11, 2021

Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR.

Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR.

Journal: Oncotarget
Published: January 16, 2018

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.

Journal: Blood
Published: January 11, 2017

Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.

Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.

Journal: Oncotarget
Published: March 22, 2016

Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.

Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.

Journal: The Journal of investigative dermatology
Published: February 01, 2016

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

Journal: Haematologica
Published: August 22, 2015

Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.

Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.

Journal: Oncotarget
Published: March 25, 2015

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

Journal: The American journal of surgical pathology
Published: February 28, 2015
Showing 1-9 of 9

Last Updated: 09/26/2026